N | |
---|---|
Number of patients | 32 |
Age -- (y) | |
Median | 60 |
Range | 34-78 |
Histological type | |
serous/serous-papillary | 31 |
Endometrioid | 1 |
Histological grade | |
G 2 | 12 |
G 3 | 20 |
Stage | |
III C | 30 |
IV | 2 |
CA 125 (U/mL) | |
Median | 1376 |
Range | (86-9030) |
CA 125 (U/mL) after preoperative treatment | |
Median | 71 |
Range | (17-2794) |
Number of chemotherapy cylcles before cytoreductive surgery | |
Two | 19 |
Three | 13 |
Residual disease after cytoreductive surgery | |
no gross residual disease | 9 |
≤ 1 cm | 19 |
>1 cm | 4 |
Lymph node status | |
N0* | 13 |
N1 | 7 |
NX | 12 |
Recurrence status (%) | |
recurrent disease | 21 |
Dead | 17 |